Sep 10, 2026
A collaborative research group led by Dr. Naoki Kubo, Team Director of the Transcriptome-Epigenome Research Team, RIKEN BioResource Research Center (BRC), and Dr. Yasuhiro Murakawa, Team Director of the Laboratory for Gene Structure and Regulation,RIKEN Center for Integrative Medical Sciences (IMS), has published a white paper proposing the next research goals and a roadmap for the International Mouse Phenotyping Consortium (IMPC), in which BRC participates.
The proposed strategy is expected to promote the functional characterization of disease-associated non-coding regions of the genome on a global scale, contributing to a better understanding of disease mechanisms and advancing precision medicine and drug discovery research through strengthened international collaboration.
The white paper was published online in Mammalian Genome on July 24, 2026.
For more information, please see the RIKEN news release, “New Strategy Proposed for International Mouse Disease Research,” published on August 28, 2026. (In Japanese only.)
This article is a translation of the RIKEN press release.
